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Clusterin (CLU) is a glycoprotein with a nearly ubiquitous tissue distribution that 
has been reported to be implicated in several physiological processes as well as in 
many pathological conditions including ageing, diabetes, atherosclerosis, degenerative 
diseases and tumorigenesis. 
In this work we studied the changes in the CLU protein expression in plasma 
samples of a Sardinian population divided by age into four groups. 
We applied a proteomic approach using 2D-PAGE-MS analyses, western im-
munoblotting and ELISA to perform comparisons between the four groups. The typical 
train of spots of the Clusterin protein in a 2D plasma map was examined and according 
to statistical analyses. Five spots were detected as being differentially expressed within 
the four groups. 
Regarding total Clusterin the results agree with the data shown by literature 
but only values up to 90 years old have been reported for Clusterin protein expression 
.This work extends to older people showing that after 90 a decrease in plasma Clus-
terin levels seems to occur especially in centenarians.  
Considering that Clusterin is a sensitive biosensor of oxidative stress it could be 
in accordance with the fact that centenarians, considered as a model of successful age-
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A brief introduction 
Clusterin (CLU) is a glycoprotein with a nearly ubiquitous tissue distribution that 
has been reported to be implicated in several physiological processes such as sperm 
maturation, lipid transportation, complement inhibition, tissue remodelling, mem-
brane recycling, cell-cell and cell-substratum interaction, stabilization of stressed pro-
teins in a folding-competent state and promotion or inhibition of apoptosis. 
Clusterin, known by several other names, has recently drawn much attention 
because of its association with cancer promotion and metastasis (S. Pucci et al., 2004, 
M. Redondo et al., 2000, B. Shannan et al., 2006). First discovered as serum apolipo-
protein J with chaperoning properties for protein stabilization, CLU also can exist 
within the cell to function in either proapoptotic or prosurvival processes. This diverse 
set of functions can be attributed to the existence of two alternatively spliced forms of 
the CLU gene that encode secretory CLU (sCLU) or nuclear CLU (nCLU). The sCLU form 
seems to be cytoprotective (K.N. Chi et al., 2008) while nCLU migrates to the nucleus 
on cytotoxic stress to trigger cell death (A.E. Caccamo et al., 2005, K.S. Leskov et al., 
2003). It interacts with the DNA double-strand break repair antigen Ku70, blocking its 
function and causing cell death (K.S. Leskov, et al., 2003). 
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Clusterin/Apolipoprotein J (ApoJ) was firstly identified in ram rete testis fluid in 
1983 as a secreted glycoprotein enhancing cell aggregation in vitro (named thus as 
Clusterin) (O. Blaschuk et al., 1983). In humans, it was firstly purified from serum and 
the cloned gene was named CLI (complement cytolysis inhibitor) (D.E. Jenne and J. 
Tschopp, 1989), SP-40,40 (secreted protein 40,40) (L. Kirszbaum et al., 1989) or ApoJ 
(H.V. de Silva et al., 1990a) due to similarities with other known apolipoproteins. 
The ApoJ gene is differentially regulated by cytokines, growth factors and stress 
inducing agents and it has been functionally implicated in many pathological condi-
tions including ageing, diabetes, atherosclerosis, degenerative diseases and tumori-
genesis.  
The ApoJ protein sequence among mammalian species is highly conserved with 
a degree of ∼70–85% and until now no functional ApoJ polymorphisms in humans 
have been found (B. Tycko et al., 1996) suggesting that the protein has evolved in ver-
tebrates to carry out a function of fundamental biological importance (I.P. Trougakos 
and E.S. Gonos, 2002). 
Although about ten years of work on this protein, there is still a lack of informa-




Chapter 1: Introduction 
PhD ANGELA BARALLA – THESIS TITLE: “CLUSTERIN/APOJ PROTEIN EXPRESSION IN PLASMA SAMPLES OF AN 
ELDERLY SARDINIAN POPULATION” -  PhD IN “SCIENZE BIOMOLECOLARI E BIOTECNOLOGICHE” – UNIVERSITY 
OF SASSARI 
   6 
 
The Human Clusterin gene 
The CLU gene is a single 9-exon expressed at very different levels in almost all 
major tissues in mammals. CLU gene maps on chromosome 8 proximal to the lipopro-
tein lipase gene locus (Fink et al.,1993). The nine exons are of variable size, ranging 
from 126 to 412 bp and spanning a region of 17,877 bp (Wong et al., 1994). Before 
2006, it was believed that a unique transcript of about 1.9 kb was the product of the 
transcription of the CLU gene, now it is known that there are three ATG start sites in 
frame with each other giving rise to three Clusterin isoforms called Isoform 1, 2 and 
11036 (F. Rizzi et al., 2009). 
The CLU gene promoter is highly conserved and contains many regulatory ele-
ments (AP-1, AP-2 and Sp1, NF1) that may regulate the complex tissue-specific control 
of the gene (Y. Herault et al., 1992, D. Michel et al., 1997, P. Wong et al., 1994). The 
conserved AP-1 site was  identified as being responsive to transforming growth factor-
beta (TGFβ) (G. Jin and P.H. Howe, 1997) and to both nerve growth factor (NGF) and 
epidermal growth factor (EGF) (C. Gutacker et al., 1999) in CCL64 and PC12 cells, re-
spectively. It was also identified a conserved domain of 14-bp (D. Michel, et al., 1997) 
that the authors called CLE element. This domain appears to be strictly related to the 
heat shock response elements (HSE), with only one base difference from the ideal HSE. 
It was, thus, proposed that this element by acting in synergy with the AP-1 element 
could make the ApoJ gene promoters particularly sensitive to environmental changes. 
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Supportively to this assumption, ApoJ gene appears to be responsive to a variety of 
both intrinsic or extrinsic factors including oncogenes, transcription and growth fac-
tors, cytokines and most stress inducing agents including oxidants, hyperoxia, pro-
teotoxic stress, heavy metals, UVA, UVB, ionizing radiation (IR), heat shock, chemo-
therapeutic drugs (S.E. Jones and C. Jomary, 2002, L.V. July et al., 2002, I.P. Trougakos 
and E.S. Gonos, 2006) and stress or apoptosis inducing agents, on a cell-type specific 
basis (I.P. Trougakos and E.S. Gonos, 2002). 
Glucocorticoid/androgen-like response elements and cyclic AMP response ele-
ments (CREs) are also present in the 5’-flanking region of the gene (F. Rizzi, et al., 
2009). 
According to the ASAP (Alternative Splicing Annotation Project) for the CLU 
UniGene cluster there are three transcripts that contain 9 exons, 8 introns and a ter-
minal 3’-UTR. All this transcript have a unique exon 1 and share the remaining se-
quence from exon 2 to exon 9. Concerning Isoform 1 , its mRNA is predicted to pro-
duce a protein of 501 amino acids with a molecular weight of 57.8 kDa. A computa-
tional prediction of its subcellular localization by the PSORT program (P. Horton et al., 
2007) suggests that the protein product should have a prevalent cytoplasmic/nuclear 
localization. Isoform 2, has an alternative untranslated exon 1; the first available ATG is 
located on exon 2 just upstream of a functional endoplasmic reticulum (ER) localization 
leader sequence thus suggesting that this isoform is destined to secretion producing a 
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protein of 449 aa. The exon I of Isoform 11036 is located on the CLU gene sequence 
just between the exon I of Isoforms 1 and 2. This sequence is not given as a RefSeq in 
the GeneBank database, but appears to be one of the most probable splicing products 
of the CLU gene. Isoform 11036 is supposed to produce a protein of 460 aa with a 
prevalent nuclear localization (P. Horton, et al., 2007). Moreover, all transcripts have a 
third ATG site in exon 3 in frame with the others ATG. Translation from this ATG would 
produce a shorter form of the CLU protein which is supposed to localize to the nucleus 
(M. Scaltriti et al., 2004). Different studies showed that these isoforms can be differen-
tially expressed in tissues. As an example, Andersen et al. demonstrated that Isoform 2 
was downregulated in cancer cells compared to normal tissue, while Isoform 11036 
was found to be expressed at very low level in normal and transformed colonic cells 
(C.L. Andersen et al., 2007). Cochrane et al. found that both the two isoforms 1 and 2 
are expressed in prostate cancer cell line but with a different regulation modulated by 
androgens (D.R. Cochrane et al., 2007). Isoform 2 is upregulated by androgens, while 
Isoform 1 is downregulated. 
It is still unclear whether transcription of each mRNA is driven by a unique 
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The Clusterin protein forms 
Three protein forms related to each other have been described with distinct 
subcellular and extracellular localization that may have different functions (A.E. Cac-
camo, et al., 2005, A.E. Caccamo et al., 2004, A.E. Caccamo et al., 2003, R.M. Moretti et 
al., 2007, S. Pucci, et al., 2004, I.P. Trougakos et al., 2005, C.R. Yang et al., 2000, Q. 
Zhang et al., 2006). 
The secreted form of CLU (sCLU of 75-80 kDa) is a glycosylated heterodimer 
present in almost all biological fluids. Translation of sCLU starts from the ATG in exon 2 
and produces a protein that is then targeted to the ER by an initial leader peptide. An 
intracytoplasmic precursor of 60-64 kDa enter the ER where it is glycosylated and pro-
teolytically cleaved at an internal site in two distinct monomers with limited homology: 
the α (34-36kDa) and β (36-39 kDa) chains linked together through five disulfide bonds 
resulting in the mature heterodimeric ApoJ protein of about 70–80 kDa. 
Additional reported post-translational modifications include sulfation (J. Urban 
et al., 1987), iodination and mannose-6 phosphorylation (P. Lemansky et al., 1999), 
while predicted putative motifs on the protein sequence include sites for phosphoryla-
tion and three nuclear localization signals (NLS) located in both the α and β chains (K.S. 
Leskov, et al., 2003). A second form of CLU protein is directed to the nucleus; this pro-
tein is detected as a 49kDa nonglycosylated precursor pnCLU (predicted molecular 
weight 48.8kDa) in the cytosol and a 55kDa glycosylated protein (referred to as nCLU) 
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in the nucleus whose enhanced expression is usually associated to cell death (A.E. 
Caccamo, et al., 2005, A.E. Caccamo, et al., 2004, A.E. Caccamo, et al., 2003, K.S. 
Leskov, et al., 2003, R.M. Moretti, et al., 2007, I.P. Trougakos et al., 2009). 
Analysis of the protein’s secondary structure revealed an enrichment in α heli-
cal domains (H.V. de Silva, et al., 1990a, H.V. de Silva et al., 1990b), while as proposed 
recently (R.W. Bailey et al., 2001) the promiscuous ApoJ binding activity with various 
dissimilar molecules may rely on three long regions of natively disordered or molten 
globule-like structures with a flexible nature containing putative amphipathic α helices.  
At physiological pH, clusterin exists as a mixture of dimers and tetramers of the 
disulfide-linked α-β heterodimer “monomer”. When exposed to mildly acidic condi-
tions, these oligomers dissociate to form α-β monomers which show enhanced binding 
to the hydrophobic probe 1-anilino-8-naphtalenesulfonate (ANS), indicating significant 
exposure to hydrophobic surfaces (A. Wyatt et al., 2009). 
ApoJ protein is constitutively secreted by a number of cell types including 
epithelial and neuronal cells, while in cells featuring a regulated exocytotic pathway its 
secretion depends on the appropriate exogenous stimulus (F. Bonavita et al., 2003, I.P. 
Trougakos, et al., 2009). Using different assays, clusterin levels in human serum has 
been reported to range from 35 to 105µg/ml (B.F. Murphy et al., 1988) and 111±50 
µg/ml (O. Blaschuk, et al., 1983).while it is about 10 times higher in human seminal 
plasma (B.F. Murphy, et al., 1988) (N.H. Choi et al., 1990) 
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Figure 1. The precursor polypeptide chain (top) is cleaved proteolytically to remove the 22-mer secre-
tory signal peptide (magenta) and subsequently between residues 227/228 to generate α and β chains. 
These are assembled in anti-parallel to give a heterodimeric molecule (bottom) in which the cysteine-
rich centers (red) are linked by five disulfide bridges (red ellipses) and are flanked by two predicted 
coiled-coil α-helices (green) and three predicted amphipathic helices (dark blue).The six sites of N-linked 
glycosylation are indicated as yellow spots (S.E. Jones and C. Jomary, 2002). 
 
 
Figure 2: sCLU precursor Is transported into the rough ER by leader signalling peptide (1), and then un-
dergoes cleavage and extensive glycosylation while being transported to the Golgi apparatus (2). The 
result is a secreted protein of~80 kDa with five disulphide bonds between the α and β subunit that is se-
creted outside the cell (3). pnCLU does not undergo any cleavage nor extensive glycosylation, and re-
sides in the cytoplasm of unstressed cells. It becomes the mature form (~55 kDa) once it is transported 
to the nucleus (S.E. Jones and C. Jomary, 2002) 
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A sensitive biosensor of oxidative stress 
CLU has been implicated in a number of physiological processes as well as in 
many pathological conditions including ageing, diabetes, atherosclerosis, degenerative 
diseases and tumorigenesis. The link between these otherwise unrelated pathologies is 
that they are characterized by increased oxidative injury. Oxidative stress occurs due 
to overproduction of oxygen-free radicals that exceed the cell’s antioxidant capacity. 
Oxygen-free radicals can be both beneficial and deleterious to the cells, in fact, low 
physiological amounts of oxidants may act as a secondary messenger in intracellular 
signalling cascades promoting normal cell homeostasis and proliferation, while abnor-
mally high levels of ROS may result in deregulation of redox-sensitive signalling path-
ways, and extensive cell damage leading to responses which include arrest or induction 
of transcription, induction of signal transduction pathways, replication errors and ge-
nomic instability, reversible growth arrest, senescence, or cellular death (G.S. Omenn, 
2006, W. Yan et al., 2009). Protein modifications refer to protein oxidation, formation 
of peroxyl radicals (G.S. Omenn, 2005), conjugation with lipid peroxidation products, 
glycation, and glycoxidation (G.S. Omenn, 2004). 
The presence in the CLU promoter of the regulatory elements AP-1 and HSF1 
that are both modulated by oxidants and oxidation injury make the CLU gene a sensi-
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tive biosensor to environmental changes and in particular to the effects of free radicals 
and their derivatives. Many oxidants induce an immediate sCLU mRNA and protein 
upregulation in human diploid fibroblasts (L. Ehrman et al., 1972) and CLU was found 
to be induced in retinal pigment epithelial cells after subtoxic oxidative stress via TGF-β 
release (N.L. Anderson and N.G. Anderson, 2002) and in human neuroblastoma cells 
under conditions of increased production of ROS and lipid peroxidation (P. Ghosh et 
al., 2001). Moreover sCLU concentration increased in human serum with exposure to 
acute in vivo oxidative stress induced by heavy metals (P. Cantos Gómez, 2009), while 
adult onset of caloric restriction that retarded age related oxidative damages resulted 
in CLU suppression in kidneys of rats (D. Howitt and D. Cramer, 2008). In another 
study, immunohistochemical analysis showed that CLU is constantly associated with 
altered elastic fibers in aged human skin binding elastin and inhibiting UV-induced ag-
gregation of this protein (S.P. Schacht and J.E. Aspelmeier, 2005). 
There is some controversy about sCLU role during cell death execution due to 
opposing reported functions (I.P. Trougakos and E.S. Gonos, 2002). In certain cellular 
types sCLU may enhance apoptosis after cell exposure to stress or apoptosis inducing 
agents (S. Gangemi et al., 2003, G. Passeri et al., 2003, M. Scaltriti, et al., 2004, I.P. 
Trougakos, et al., 2005) and high amount of CLU may become cytotoxic when accumu-
lated intracellularly (R.A. Rabini et al., 2003).  
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On the other hand, in CLU-/- mice, sCLU was found to confer protection from 
autoimmune myocardial damage (R. Coppola et al., 2003), permanent focal cerebral 
ischemia (J. Delay et al., 1954), heat-shock mediated in the testis (R.W. Bailey et al., 
2002) and progressive age-related glomerulopathy (M.E. Rosenberg et al., 2002). 
Moreover, sCLU biosynthesis inhibition by antisense oligonucleotides or small interfer-
ing RNA (siRNA) resulted in significant cell sensitization to apoptosis induced by oxida-
tive stress (I. Viard et al., 1999). Other reports indicate that even in the absence of ex-
ternal stress sCLU knock down reduces cell proliferation and increases the rates of 
spontaneous apoptosis in normal or cancer mammalian cell types (S.W. Kang et al., 
2000, M.R. Schlabach et al., 2008). Recent findings indicate that sCLU inhibits apop-
tosis by specifically interacting with conformation altered activated Bax in the mito-
chondria (H. Zhang et al., 2005). 
These findings indicate that sCLU may have an important function even in the 
absence of stress having a vital housekeeping role in the maintenance of cellular pro-
teome stability (I.P. Trougakos and E.S. Gonos, 2009).  
nCLU contrary to sCLU has been correlated to a pro-death function that is me-
diated through a nuclear localization and Ku70 binding after exposure to IR (S. Siegel 
and N.J. Castellan, 1988, I.P. Trougakos et al., 2002) or due to its ability to dismantle 
the actin cytoskeleton (L. Gaspari et al., 2003). 
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Implications of CLU in ageing and age related diseases 
Ageing is a consequence of complicated interactions between genetic factors 
along with the accumulation of a variety of stochastic changes over time due to a pro-
gressive failure of homeostasis that promotes multiple biochemical, molecular and cel-
lular changes which lead to increased disability, morbidity, and to death (T.B. Kirk-
wood, 2002). So ageing is a multifactorial process modulated by the interplay among 
genetic and environmental factors (R. Holliday, 1998, N. Lane, 2003). Increased levels 
of ROS can lead to deleterious by-products. This increasingly damaging process can be 
responsible for degenerative diseases and ageing. During in vivo ageing  CLU gene ex-
pression was found to increase from gestation to adults in humans (P. Wong, et al., 
1994), in the human pituitary gland (T. Ishikawa et al., 2006), in the rat ventral prostate 
(K.M. Lau et al., 2003), in human glial cultures (N.V. Patel et al., 2004) and in human 
lymphocytes (I.P. Trougakos et al., 2006). In serum sCLU levels seems to increase dur-
ing in vivo ageing at least in males (I.P. Trougakos, et al., 2002). Considering that age-
ing is a risk factor for many severe diseases including cancer, vascular diseases and 
neurodegeneration it is not surprising that CLU has been implicated in all these patho-
logical conditions. 
During vascular damage sCLU was found to accumulate in the human serum of 
diabetes type II patients or during myocardial infarction (I.P. Trougakos, et al., 2002). 
sCLU accumulates in the artery wall during atherosclerosis suggesting that can have a 
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protective role against the oxidative stress associated with the development of the 
disease (B. Mackness et al., 1997). 
CLU mRNA synthesis is particularly evident in the normal adult brain of some 
mammalian species and during neurodegenerative conditions there is a significant in-
crease of its expression. sCLU was found to associate with amyloid β-peptide in senile 
and diffuse plaques of Alzheimer Disease (E. Kida et al., 1995). Yerbury et al. In 2007 
suggested  that the proamyloidogenic effects of CLU may be explained considering the 
CLU:client protein ratio, in particular when the substrate protein is present in high 
concentration, CLU coincorporates with it  into insoluble aggregates, while when CLU is 
present in higher levels it potently inhibits amyloid formation confering cytoprotection 
(J.J. Yerbury et al., 2007). CLU expression seems to be correlated with an anti-
inflammatory function, for example, it was found to exert a cytoprotective function in 
lung during leukocyte-induced injury (A.R. Heller et al., 2003) in inflammatory exocrine 
pancreas (V. Savkovic et al., 2007) and in glomerulonephritis (M.P. Rastaldi et al., 
2006). Finally, CLU has been functionally implicated in all aspects of tumorigenesis in-
cluding tumor formation and progression, metastasis and chemoresistance acquisition 
(B. Shannan, et al., 2006, I.P. Trougakos and E.S. Gonos, 2002). 
In all these pathological conditions the main mission of CLU would be to cease 
the deleterious effects of oxidative stress. If this is true, than CLU gene expression and 
protein upregulation during ageing should reflect the general “oxidative status” of the 
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subject rather than its chronological age (I.P. Trougakos and E.S. Gonos, 2009). In fact, 
Franceschi et al., showed that although CLU gene expression levels in lymphocyte 
samples are higher in old donors compared to their younger counterparts, in similar 
samples from centenarians (a model of successful ageing characterized by low ROS 
load) , CLU gene expression levels where significantly lower than those found in the old 
donors (C. Franceschi and M. Bonafe, 2003). 
 
Chaperone activity of CLU 
Molecular chaperons are a large family of ubiquitous proteins that appeared 
early in evolution to form a defensive system in cells by sequestering damaged pro-
teins and preventing their aggregation. Much of the current understanding of molecu-
lar chaperons centres on the heat-shock protein (HSP) family and their action include: 
1) ensure correct folding of newly synthesized polypeptides 2) unfold and refold poly-
peptides during translocation across membranes, 3) assemble and disassemble mac-
romolecular complexes, or 4) resolubilise or facilitate the degradation of partially 
folded and/or aggregated proteins. 
sCLU shares functional similarities with HSPs and similar expression pattern, 
but, the presence of different regulatory elements in the CLU gene promoter makes 
CLU gene more sensitive than HSPs in various environmental insults.  
Humphreys et al., 1999 provided for the first time evidence to the hypothesis 
that Clusterin may function as a molecular chaperone (D.T. Humphreys et al., 1999) 
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and further studies highlighted Clusterin’s ability to inhibit the stress induced aggrega-
tion and precipitation of a quantity of unrelated target proteins (S. Poon et al., 2000, S. 
Poon et al., 2002). Clusterin, like sHSPs binds to stressed target proteins forming high-
molecular weight complexes, even if it is not clear how this interaction occurs.  Al-
though its ability to stabilize aggregation-prone proteins, Clusterin is unable to restore 
the stress-induced loss of enzyme activity of alcohol dehydrogenase, catalase and glu-
tathione-S-transferase because it is unable to refold these enzymes alone but it can 
maintain stressed proteins in a state that is competent for subsequent refolding by 
heat-shock cognate protein 70 (HSC70) (S. Poon, et al., 2000).  
Different reports described the ability of clusterin to inhibit the in vitro fibrillar 
aggregation of the amyloid β (Aβ) peptide, the major component of senile plaques as-
sociated with Alzheimer’s disease (E. Matsubara et al., 1995). However Clusterin has 
been found associated with all disease-associated extracellular protein deposits tested 
to date, including amyloid deposits (J.J. Yerbury, et al., 2007). The presence of clusterin 
in these deposits, as stated in the previous paragraph, may indicate its incorporation 
into insoluble aggregates under conditions in which the capacity of extracellular pro-
tein folding mechanisms have been exceeded. 
A supposed main difference between sCLU and sHSPs (small heat shock pro-
teins) seemed to be their differential localization. sHSPs localize mainly in the cytosol 
and nucleus (A.P. Arrigo et al., 2007) whereas sCLU, because of the ER targeting hy-
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drophobic signal peptide were expected to reside in the membranous compartments 
of the cell as well as in the extracellular milieu (M. Calero et al., 2005, B. Shannan, et 
al., 2006). Due to this different localization Trougakos et. al., suggested that sCLU may 
represent the only chaperone that confers proteome stability both extra and intracel-
lularly (I.P. Trougakos and E.S. Gonos, 2009). 
 
sCLU involved in signalling pathways for cell survival 
CLU gene expression is upregulated in tumors of various origins (H.J. Ahn et al., 
2008, B. Shannan, et al., 2006). It is further increased under conditions known to in-
duce apoptosis, such as hormone withdrawal in estrogen-dependent breast tumor or 
in androgen-dependent prostate cancer models (A. Brandstrom et al., 1994) and other 
conditions involving cell death, such as tissue remodelling and injury (M.G. Bandyk et 
al., 1990). sCLU has now been clearly found to be cytoprotective in the presence of 
apoptosis and necrosis (H. Miyake et al., 2000, J.A. Sensibar et al., 1995, B. Shannan, et 
al., 2006). A possible way by which sCLU exerts its protective function is binding to a 
cellular receptor. The first identified sCLU receptor is Megalin (M.M. Bartl et al., 2001) 
that belongs to the LDL receptor family (LDLR) of structurally related membrane recep-
tors. These receptors bind preferentially lipoproteins and various proteins like prote-
ase inhibitors (D.K. Strickland et al., 1995, D.K. Strickland and S. Ranganathan, 2003), 
and internalize them by endocytosis. 
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Ligand binding to these receptors (VLDL receptor, the apoE receptor 2, LRP1 
and megalin) can promote signal transduction and it has been demonstrated that sCLU 
can interact with all of them. Ammar and Closset in 2008 evidenced that sCLU binding 
to its receptor megalin activated the P13 kinase /Akt pathway and produced multiple 
protein phosphorylation (H. Ammar and J.L. Closset, 2008). Moreover, protection by 
sCLU induced signalling  was not blocked when inhibiting P13 kinase/Akt pathway, 
suggesting that additional pathways can be involved in the cell protective function of 
sCLU (G. Klock et al., 2009). Shim et al. showed that sCLU stimulates astrocyte prolif-
eration by modulating EGF receptor signalling activity, resulting in MEK/ERK stimula-
tion (Y.J. Shim et al., 2009). However, the potential signaling functions of sCLU remain 
still to be clarified. 
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Ageing and Longevity 
 
 
Complex trait where environmental, genetic and stochastic factors are 
involved 
Ageing and longevity are complex phenomena influenced by multiple genetic 
and environmental factors (N. Barzilai and A.R. Shuldiner, 2001, P. Hamet and J. 
Tremblay, 2003, T. Perls and D. Terry, 2003). Genes or the environment can promote 
longevity by either protecting individuals from age-related illnesses or by slowing 
down the ageing process (N. Barzilai and A.R. Shuldiner, 2001, T. Perls et al., 2002). En-
vironmental factors that may have a strong influence on the lifespan include physical 
activity (T.H. Lam et al., 2004), smoking (D.H. Taylor, Jr. et al., 2002), diet (F. Seccarec-
cia et al., 2003), and also caloric restriction in animals (L.K. Heilbronn and E. Ravussin, 
2003, L.H. Mehta and G.S. Roth, 2009). A strong relationship between genetics and 
longevity is suggested by studies of life expectancies of subjects who have reached a 
very old age and their offspring (T. Perls, et al., 2002). Different studies indicate that 
gene polymorphisms can contribute to human longevity through different mecha-
nisms, including the immune systems and the metabolic systems (G. Atzmon et al., 
2006, N. Barzilai et al., 2003, C. Franceschi et al., 2005) and recently RNA editing genes 
have been reported to be important regulators of ageing in humans (P. Sebastiani et 
al., 2009). 
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Moreover, proteomic analyses represent a great potential to study cellular and 
tissue protein alterations in various disease states and ageing (H.J. Hwang et al., 2009, 
E. Schiffer et al., 2009, F. Sun and V. Cavalli). However, proteomic studies on human 
longevity are still limited. 
Centenarians represent a group of individuals in the population that escaped 
neonatal mortality, antibiotic era illnesses, and avoided or postponed the most severe 
age-related diseases and their fatal outcomes (S. Salvioli et al., 2008). For this reason, 
these individuals have been an extraordinary model to study human longevity and 
healthy ageing. Moreover, it should be highlighted that within this group of excep-
tional individuals, a consistent part of them (about one third) are in good health (C. 
Franceschi et al., 2007, S. Mariotti et al., 1993). 
Among the many factors involved in human longevity, one that might be cited 
is the gender. It is well established that females have a longer life expectancy than 
males (about 4 years in developed countries). Among very old people, females out-
number males of the same age. In particular, when centenarians are considered, the 
male/female (M/F) ratio has been reported to range between 1:4 and 1:7 (A.M. 
Menard et al., 1992, P. Sammallahti et al., 1996). However, a surprising 1:2 ratio has 
been reported for Sardinian centenarians (L. Deiana et al., 1999). This Sardinian data 
has been much discussed, and researchers of the field attributed it to either the pecu-
liarity of the Sardinian population or environmental effects (G. Passarino et al., 2002). 
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Although ageing processes may be biologically modulated in many tissues, lon-
gevity is also determined by escaping from common killing diseases: cardiovascular 
disease, cancer, and infection are the leading causes of death in adults. Thus, in addi-
tion to possibly finding genes and proteins that modulate the ageing process, research 
on human longevity is also likely to identify genes that protect from these diseases. 
Consequently, the discovery of longevity-associated genes and proteins will lead to 
fundamental understandings of the molecular basis of several important diseases hav-
ing a profound impact on morbidity, mortality, and enhancing the quality of life in the 
elderly population (N. Barzilai and A.R. Shuldiner, 2001). 
 
Theories of ageing 
Theories formulated to explain ageing processes have been grouped into two 
principal categories: the “programmed” and “error” theories of ageing (B.T. Weinert 
and P.S. Timiras, 2003). According to the “programmed” theories, ageing depends on 
regulation of genes sequentially switching on and off signals to the nervous, endocrine, 
and immune systems responsible for maintenance of homeostasis and for activation of 
defence responses. The “error” theories identify environmental insults to living organ-
isms that induce progressive damage at various levels (e.g., mitochondrial DNA dam-
age, oxygen radicals accumulation, cross-linking) (B.T. Weinert and P.S. Timiras, 2003). 
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Between these two categories we can identify evolutionary (L.A. Gavrilov and 
N.S. Gavrilova, 2002, G. Rose et al., 2007), molecular, cellular and system-based theo-
ries (B.T. Weinert and P.S. Timiras, 2003). 
The evolutionary theories include the mutation accumulation theory that sug-
gests that there are purely deleterious mutations that have no effect earlier in life but 
exert their effects later. These mutations would tend to accumulate in the population 
because of their minimal effects on fitness. Evolutionary theories argue that ageing re-
sults from a decline in the force of natural selection. Because evolution acts primarily 
to maximize reproductive fitness in an individual, longevity is a trait to be selected only 
if it is beneficial for fitness. The essential concept in these theories is that the balance 
of resources invested in longevity vs. reproductive fitness determines the lifespan (B.T. 
Weinert and P.S. Timiras, 2003).  
Molecular theories of ageing proposes that senescence results from changes in 
gene expression (gene regulation theory) (M.S. Kanungo, 1975). System-based theories 
of ageing explain it in terms of alterations in neuroendocrine functions controlling ho-
meostasis, which result in physiological changes (neuroendocrine theory), by increased 
susceptibility to infectious and autoimmune diseases due to a decline in immune func-
tion (immunological theory), or by assuming a fixed metabolic potential for living or-
ganisms (rate of living theory) (B.T. Weinert and P.S. Timiras, 2003). 
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Cellular theories include the cellular senescence-telomere and free radical 
theories. Cellular senescence has been described as limiting cell divisions in cell cul-
tures. This has been ascribed to the loss of telomeres from the chromosome endings 
or the loss of telomerase function (C. Martin-Ruiz et al., 2004, K. Masutomi et al., 
2003). The free radical theory, suggests that ageing is the result of cumulative effects 
of oxidative damage to various cellular structures such as DNA, proteins and lipids (A.P. 
Wickens, 2001). 
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The human plasma: complexity of the sample 
 
 
Human plasma and serum are the preferred specimens for non-invasive studies 
of normal and disease-associated proteins in the circulation and arising from cells 
throughout the body. Blood plasma contains several different water-soluble compo-
nents, among them the blood plasma proteins. In principle, any protein present in the 
body can become at least temporarily a blood plasma protein depending on the actual 
state of the body, e.g. especially in the case of a pathological situation. A protein that 
is usually not present in blood plasma may accumulate in blood plasma and function as 
a characteristic diagnostic marker for a certain disease. Most plasma proteins carry 
post translational modifications (PTMs), either permanently or temporarily, and the 
vast majority are glycoproteins, thus ensuring a reasonable solubility. Blood plasma 
proteins exhibit a wide variety of functions and have different structural properties; 
moreover they cover a very wide concentration range of at least 10 orders of magni-
tude (see Fig.3). 
The most abundant by far, albumin being 40 mg/mL, while cytokines and kallik-
reins (including prostate-specific antigen [PSA]) are at about 1 ng/mL, arriving to much 
lower concentrations with proteins of tissue origin. From 40 mg/mL to 4 pg/mL is 10 
orders of magnitude. The most common technology for fractionating and identifying 
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proteins, 2D gel electrophoresis (2DE), has a range of detection of not more than 3 or-
ders of magnitude. Other methods have similar or slightly larger ranges. Plasma has a 
far larger dynamic ranges than tissue or other body-fluid specimens and albumin ac-
counts for approx 50% of the total mass of proteins in the plasma. Another several 
proteins account for about 40% of total protein mass (P. Ping et al., 2005). The most 
abundant 22 proteins are estimated to account for 99% of total protein mass (N.L. 
Anderson and N.G. Anderson, 2002). Table 2 lists particularly abundant and readily de-
tected proteins, with their usual concentrations. Abundance is an extremely important 
variable, not only because more abundant proteins are more readily detected, but also 
because the peptides and peptide ions from these proteins compete against peptides 
from other proteins in identification by mass spectrometry (MS). Thus, several meth-
ods have been developed for depletion of highly abundant proteins in plasma. 
 
 
Figure 3: Dynamic range of proteins in plasma (V. Thongboonkerd, 2007),fM femtomolar, pM picomolar, 
nM nanomolar, µM micromolar, mM millimolar. 
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When blood is collected, many more changes in proteins may occur due to pro-
teolytic enzymes (proteases) and other enzymes that are active in the blood sample 
during handling and processing. Plasma is protected from clotting by use of one of 
three different anticoagulants: sodium citrate, K2-EDTA, or lithium heparin. Each has its 
own characteristics; citrate and EDTA have desirable features of antiprotease activity. 
Some investigators add a protease inhibitor cocktail containing both peptide and small 
molecule inhibitors (15). The peptide(s) may compete directly with and interfere with 
the detection of peptides in the mass spectrometer, whereas such small molecules as 
ABESF, a sulfonyl fluoride, have been shown to form covalent bonds with proteins and 
thereby shift the isoelectric point (pI) of the protein (16). Omenn et al. suggested that 
plasma samples are preferable to serum samples because there is less degradation ex 
vivo and much less variability than arises in the protease-rich process of clotting. Clot-
ting is unpredictable, owing to influences of temperature, time, and medications, 
which are difficult to standardize. These authors also recommend the use of EDTA over 
heparinized plasma because heparin acts through activation of antithrombin III, 
whereas citrate and EDTA inhibit coagulation and other enzymatic processes by che-
late formation with ion dependent enzymes, but the use of EDTA is preferable because 
citrate introduces a 10 to 15% dilution effect. Moreover they did not recommend in-
clusion of protease inhibitors in the collection tubes or buffers because they can alter 
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analyses as shown the small molecule inhibitor ABESF which forms covalent bonds 
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The aims of the present study were to compare the typical train of spots of the 
Clusterin protein in 2D plasma maps between four groups of people divided by chrono-
logical age, to perform a semi-quantitative analysis of the expression of the secreted 
form of Clusterin with western blotting as well as to compare total Clusterin concen-
tration values in the plasma samples of the four groups. 
The Sardinian people analysed were recruited through the AkeA project that 
studies longevity in Sardinia and includes plasma samples of people spanning from 20 
to 100 years and more and so another aim was to investigate Clusterin expression in 
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Samples 
Plasma samples for this study were recruited from the AKeA project (the name 
‘AKeA’ is derived from an expression in the Sardinian language that means ‘health and 
life for 100 years!’) that studies the Sardinian centenarians (L. Deiana, et al., 1999). 
For 2D analyses we selected a group of 7 centenarians, 12 aged 90-99, 12 aged 
80-89 and 10 controls aged 20-50. While for ELISA validation we increased the number 
of samples in this way: 18 centenarians (10M, 9F), 17 aged 90-99 (9M, 8F), 15 aged 80-
89 (8M, 8F) and 18 controls aged 20-50 (9M, 10F). 
None of the partecipants in this study were in an acute care situation. The con-
trol subjects were 10 healthy volunteers aged 20-50 years (mean age 35) without dis-
eases or relevant history, such as vascular disease, stroke, diabetes or cancer. 
All patients gave informed consent prior to collection of blood samples. 
 
Plasma sample  
For plasma separation, whole blood (7.5 mL) was collected in EDTA-coated 
tubes, mixed immediately and incubated for about one hour to allow the samples to 
be transported to the laboratories. The red cell fraction was then separated by cen-
trifugation at 2500 g at 4 °C for 15 min and the clear plasma supernatant was stored in 
aliquots frozen at -80 °C. 
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Removal of albumin from serum samples 
Abundant proteins, such as albumin, hide the detection of many low-
abundance proteins, some of which might potentially be relevant to particular disease 
states. 
For protein extraction we used the modified TCA (trichloroacetic acid)/acetone 
precipitation method by Chen et al., which showed evidence of efficient removal of al-
bumin in mouse serum. Levine (M. Levine, 1954) and Delaville (M. Delaville et al., 
1954) have reported that human and bovine serum albumins after TCA precipitations 
are soluble in organic solvents, such as methanol, ethanol, and acetone. Chen et al. 
tested the effect of adding different volumes of 10% TCA/acetone to aliquots of hu-
man serum concluding that most of the abundant albumin was effectively removed 
from the remaining serum proteins when adding four volumes of 10% TCA/acetone. 
We simply applied the same method to plasma samples with a satisfactory result in the 
gels obtained through bidimensional electrophoresis. 
A 20 µL sample of human plasma was precipitated by adding four volumes of 
ice-cold acetone containing 10% w/v TCA and immediately mixed by gentle vortexing. 
The mixture was incubated at -20°C for 90 min and centrifuged at 15.000 g at 4°C for 
20 min. The supernatant was removed and collected. After that, 1 mL of ice-cold ace-
tone was added to wash the precipitate. The sample was incubated on ice for 15 min 
and centrifuged as above. The acetone-containing supernatant was removed and the 
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precipitate was risolubilised with sonication in sample buffer containing the chaotrope 
8M Urea to prevent protein aggregation and the detergent CHAPS 4% to increase the 
solubility of certain proteins. 
 
Protein quantification 
The protein concentrations of the plasma samples were determined through 
the DC protein assay (BioRad) according to the manufacturer’s instructions. 
The DC Protein Assay uses a modified Lowry assay based on the reaction of pro-
tein with an alkaline copper tartrate solution and Folin reagent where the color devel-
opment is primarily due to the amino acids tyrosine and tryptophan, and to a lesser ex-
tent, cystine, cysteine, and histidine. Proteins reduce the Folin reagent by loss of 1, 2, 
or 3 oxygen atoms, thus producing one or more of several possible reduced species 
which have a characteristic blue colour with a maximum absorbance at 750 nm. Stan-
dard curve was constructed using albumin as standard sample in a range between 0.2 
and 2mg/ml. In order to obtain concentrations of the buffer compounds compatible 
with the assay and the one of the sample inside the range of the curve constructed we 
diluted samples in two steps, a first dilution 1:2.5 of the sample in buffer containing 
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Two dimensional SDS PAGE 
Isoelectrofocusing (IEF) 
After protein extraction and quantification the first dimension of the 2D-SDS 
PAGE was performed on isoelectric focussing (IEF) strips with pH 4-7 (IPG strips 4-7, 17 
cm from BioRad). At first, the strips were rehydrated for 20 hours in rehydration solu-
tion (Urea 8M, Tiourea 2M, 4% CHAPS, Destreak reagent, 10mM DTT, 1% carrier am-
pholyte 4-6 and 0.05% bromophenol blue) and covered with mineral oil. After rehydra-
tion, 1000 μg of proteins were applied onto IPG strips and proteins were separated in 
the first dimension according to the following protocol: 250 V for 2 h, 500 V for 2 h, 
750 V for 2 h, 1000 V for 2 h, 5000 V for 2 h and 8000 V for 50.000 Volthours, for a to-
tal of 80.000 Vh. After isoelectric focusing the IPG strips were equilibrated in a two 
step equilibration protocol: 
The equilibration buffer (EQ) contained 50 mM Tris-Cl pH 8.8, 6M urea, 20% 
(v/v) glycerol and 2% (w/v) SDS. For the first equilibration step 2% DTT were added to 
the EQ buffer. For the second step 2.5% iodoacetamide and 0.005% bromphenolblue 
were added. Equilibration steps were done at room temperature for 15 min each. 
 
SDS-PAGE 
To separate proteins according to their size denaturing sodium dodecylsulfate 
polyacrylamide gel electrophoresis (SDS PAGE) was performed. Strips were embedded 
into 5% agarose on top of SDS polyacrylamide gels. The anionic detergent sodium do-
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decyl sulfate (SDS) denatures the proteins and provides the protein with a negative net 
charge. For the second dimension 5-15% gradient SDS acrylamide/bisacrilamide gels 
were used. The gradient gels were produced using the Gradient Former Model 495 and 
the Multicasting Chamber from BioRad. Using this apparatus we were able to produce 
ten gels simultaneously with a high reproducibility. The gels were run on a Protean 
Multicell (BioRad) were six gels at a time can be run. The instrument is connected to a 
cooling bath to avoid excessive heating of the buffer. The lower chamber was filled 
with buffer containing Tris 0.125M, Glycine 0.96M, SDS 1%, while the upper chamber 
had the same composition but with the SDS concentration doubled (2%). This modifi-
cation was suggested by the work of Werner et al. who proved that in order to mini-
mize gel smearing the concentration of SDS in the cathodic buffer needs to be in-
creased. After completion of the run, gels were stained in Coomassie staining solution 
that can detect protein spots with concentrations between 3 ng – 15 ng (Westermeier 
and Marouga 2005) which is typically enough protein to obtain mass spectrometry re-
sults using MALDI-TOF MS (matrix-assisted laser desorption ionisation time of flight 
mass spectrometry). Coomassie staining is cheap, quantitative and reproducible. The 
staining solution used was composed of 0.05% coomassie Blue R-250 dissolved in 50% 
methanol, 10% acetic acid and H2OmilliQ. Gels were then washed with H2OmillQ and 
destained in destaining solution contained the same components of the staining solu-
tion except for the dye. Gels were scanned using a GS-800 densitometer from BioRad. 
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Image analysis  
Images were analysed using the PDQuest 2D Analysis Software (BioRad). Before 
performing the analysis we cropped the images to the area containing the train of 
spots of interest (the one of clusterin) and then we performed the image analysis fol-
lowing the steps summarized below: 
 Scanning: gels are turned into pixel data and then each map is turned into a se-
ries of pixels describe by their optical density value (OD). 
 Filtering: this step eliminates noise, background effect. 
 Automated spot detection: identification of spots present in each gel in-
dipendently, then spots are located on the gel image fitted by ideal gaussian 
distributions and quantified by the sum of the OD values within each gaussian 
distribution. 
 Matching of protein profiles: 2D gels are then edited and matched to one an-
other in a “match set”, to achieve this, landmarks are used, consisting of refer-
ence spots used by PDQuest to align and position the match set members for 
matching. 
 Normalization: is used to compensate gel to gel variations due to sample 
preparation and loading, staining and de-staining procedures. 
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 Spots were first detected and matched automatically to a master gel selected 
by the software and then we corrected manually the errors in the editing end 
matching steps. 
 Spot volumes were normalised with the option “total quantity in valid spot” 
where the raw quantity of each spot in a member gel is divided by the total 
quantity of all the spots in that gel that have been included in the Master  . The 
quantity table was exported to a spreadsheet .xls file and submitted to statisti-
cal analyses. Features that displayed statistically significant changes in their 




All the statistical analyses were performed using the software SPSS v.17. For 2D 
spot intensity comparisons we performed and compared a parametric test, The One 
Way ANOVA followed by “Fisher’s least significant difference method” (LSD) and a non 
parametric one The Kruskal Wallis test which doesn’t assume a normal distribution of 
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Western blot 
For western blot analyses the same extracts (proteins in urea and CHAPS) used 
for 2D PAGE were analysed. The samples were boiled in laemli buffer (TrisHCl 1M 
pH6.8, glicerol, 10% SDS, 0.5% bromophenol blue) for 4 minutes at 95°C and then 
loaded on a 12% acrylamide gel. After SDS PAGE the gel was transferred to a nitrocellu-
lose membrane using the Mini Trans Blot system from BioRad. The gel size was meas-
ured and two whatman filter papers and one nitrocellulose membrane of the same 
size were prepared. The filter papers and nitrocellulose were soaked in transfer buffer 
(25mM Trizma base, 200mM glycine in H2O milliQ). Then the soaked nitrocellulose and 
the polyacrylamide gel were placed on to one of the filter papers and covered with the 
second filter paper. This stack was placed between two sponge cloths before they 
were placed into the holding device of the blot chamber. Blotting was performed at 
350mA for 1 hour. During the blotting procedure, the entire apparatus was placed in a 
box with ice to avoid heating of the buffer. After disassembling, the membrane was 
soaked in blocking buffer containing 3% albumin in PBS-T (PBS 10X, 20% (v/v) metha-
nol 0.05% (v/v) and Tween-20 in ddH2O) for 1 hour at room temperature. It was then 
shortly rinsed with washing buffer (PBS-T) and the primary antibody (dilution 1:500) 
was applied in the same buffer overnight at 4°C. The blots were washed 3 times for 10 
min in washing buffer before the secondary horseradish peroxidase labelled goat anti-
rabbit antibodies was applied in the same buffer at a dilution of 1:2000 for 80 minutes 
at RT. The membranes were washed five times in PBS-T before the blots were devel-
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oped using the ECL Immunoblotting Detection Kit from Amersham. An excess of the 
applied developing solution was removed and the membrane was covered with saran 
wrap before detection with the Versa Doc device from BioRad. The exposure time was 
set at 180 sec and then the image acquired for densitometric studies. 
 
Mass spectrometric analysis of proteins  
Mass spectrometry is the most common, high throughput method for identify-
ing proteins from 2D gels. It accurately weighs peptides after digestion with a suitable 
enzyme and the masses of these peptides can then be matched against the theoretical 
peptide masses of known proteins for identification. In the present work, selected 
spots were cut from gels, and sent to Porto Conte Ricerche for identification. The spots 
were digested with trypsin enzyme and analysed with a nano (HP-1200) LC-MS/MS ion 
trap mass spectrometer (XCT Ultra 6340) from Agilent Technologies (Palo Alto, CA). LC-
MS/MS combines the separation capabilities of liquid chromatography with the accu-
rate mass analysis of mass spectrometry. The database searches were performed using 
MASCOT available at www.matrixscience.com. We set the mass tolerance at 300 ppm, 
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ELISA 
A competitive ELISA kit (AdipoGen, Korea) for human clusterin was used follow-
ing manufacturer instructions. 
 
REAGENTS 
IPG strips pH 4-7 17cm, were purchased from BioRad Laboratories (Hercules, 
CA,USA), Ampholyte 4-6, Dithiothreitol (DTT), urea and thiourea from Sigma-Aldrich 
(St. Louis, MO, USA). Goat Polyclonal antibody Anti-clusterin-α (human) (C-18) sc-6419 
and HRP-conjugated anti-goat IgG were purchased from Santa Cruz Biotechnology (CA, 
USA), Magic Mark XP western protein standard from  Invitrogen (Carlsbad, CA, USA), 
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To explore the changes in the protein expression of the CLU protein a 2D-PAGE 
study was performed. After preparation of plasma samples with the method of Celis et 
al. for the removal of great part of albumin, a 2DE protein map in the pH range 4-7 was 
prepared for each sample. In the typical 2D plasma map available on SWISS 2D-PAGE 
from Expasy Proteomic Server (www.expasy.org) Clusterin appears as a train of spots 
whose isoelectric points extend from 4.65 to 5.65 and their molecular weight are in the 
range between 32KDa and 40KDa positioned under the train of haptoglobin β chain 
spots. The presence of this train of spots is generally caused by a variability in syalia-
tion of the different protein glycoforms (P. Ghosh, et al., 2001) The fig. 5 shows a typi-
cal 2D plasma map obtained in our laboratory through the method described in mate-
rials and methods with a zoom (fig. 6) on the clusterin spots. The figure 5 also shows 
the typical position of most abundant plasma proteins. 
The Gels were analyzed using the PDQuest 2D Analysis basic software and the 
images cropped in the area of interest (containing the train of clusterin spots) before 
performing the image analysis. We realized that this step had a positive and a negative 
aspect, the positive one was that it allowed us to have a better visualization of all the 
spots on the computer screen and to better perform the editing and matching of the 
spots in the sample group without a lot of zooming on the images, while the negative 
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one is that we couldn’t perform the normalization “total density in gel image” because 
cropping the image we have lost the total intensity of it. For this reason we used the 
“total quantity” in valid spot normalisation. 
The software used is not designed to compare more than 15 images at a time 
per experiment so we decided to use a single experiment “matchset” for each group, 
the spot intensities were normalised and the quantity table exported for future analy-
sis. For each “matchset” (4 groups) we had different SSP (standard spot number) num-
bers assigned by the software, to overcome this problem we annotated all the spots 
manually with visual inspection in order to have the same number for matched spots 
between the four groups. At this point we had 4 comparable spot quantity tables with 
which we performed all the statistical analysis with the software SPSS statistics v.17. 
The fig. 4 shows a typical screen of a matchset in PDQuest. 
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Figure 4: Matchset example created by PDQuest software, the yellow crosses indicate the clusterin 
spots and the image on the left represents the master gel which contains all the spots that appear in 
each of the sample images. 
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Figure 5: Typical gel image obtained in our lab for plasma proteins after removal of a great part of albu-
min in a gradient gel 5-15%. 
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To analyse the differential expression of clusterin spots between groups of gels 
we decided to use two statistical tests that are alternatively used for proteomic analy-
ses, a parametric and a non parametric one. The One-Way ANOVA parametric test, can 
be used for comparing means when there are more than two levels of a single factor 
(in our case “the age”: 4 groups). However, the ANOVA doesn’t identify which means 
are different, methods for investigating this issue are called multiple comparisons 
methods, in this work we used the “Fisher’s least significant difference method” (LSD) 
to identify which means were different. The ANOVA test is a very powerful parametric 
test but the data must respect the restrictive assumptions (normal distribution of the 
dataset, homogeneity of variance and independent samples). Although some empirical 
evidence illustrates that slight deviations in meeting the assumptions underlying pa-
rametric tests may not have drastic effects on the obtained probability levels, there is 
no general agreement as to what is a “slight” deviation (S. Siegel and N.J. Castellan, 
1988).  
In total we had 44 variables to analyse, obviously the clusterin spots are not so 
numerous but this number represents all the spots present in all samples of all the 
groups, having a mean of 30 spots in each master gel created by the the group experi-
ment. So while the matched spots to all gels were only five or six in some groups, the 
unique spots present in each gel of an experiment (matchset) increased the number to 
analyse to 44. 
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For the reasons cited above, before applying the ANOVA test we performed the 
Levene Test for Homogeneity of Variances and found that on the 44 variables (our 
clusterin spots from all the groups) there were 9 spots that didn’t pass the test. In 
ANOVA table (table 1) only the spots with a p-value ≤ 0.05 are listed eliminating those 
that didn’t pass the test for omogeneity of variance. 
We further investigated our data performing a non parametric test the Kruskal-
Wallis Test (table 2) which doesn’t assume a normal distribution of the samples, to see 
if there was a similarity between the spots identified. 
The spots identified by the ANOVA test were 10, while those identified by the 
Kruskal-Wallis Test were 21. We can notice that not all the spots identified by the two 
tests were the same; the spots unique for each test are highlighted in blue in the re-
spective tables. The figure 7 below shows the positions of the spots identified by the 
ANOVA analysis on the master gel images of each group. 
 
ANOVA LSD 
Spot  Sum of Squares df Mean Square F Sig. 
Group       
difference 
V3 
Between Groups 2,479 3 0,826 3,524 0,023 
50 vs 100 
80 vs 100 
90 vs 100 
Within Groups 9,849 42 0,234    
Total 12,328 45     




50 vs 100 
80 vs 100 
90 vs 100 
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Within Groups 6,009 42 0,143    
Total 10,372 45     
V12 
Between Groups 18,222 3 6,074 3,926 0,015 
50 vs 90 
80 vs 90 
90 vs 100 
Within Groups 64,987 42 1,547    
Total 83,209 45     
V13 
Between Groups 50,030 3 16,677 4,396 0,009 
50 vs 90 
80 vs 90 
90 vs 100 
Within Groups 159,323 42 3,793    
Total 209,352 45     
V2307 
Between Groups 151,762 3 50,587 4,558 0,007 
50 vs 100 
80 vs 100 
90 vs 100 
Within Groups 466,132 42 11,098    
Total 617,894 45     
V3305 
Between Groups 34,614 3 11,538 3,076 0,038 
50 vs 80 
80 vs 90 
80 vs 100 
Within Groups 157,565 42 3,752    
Total 192,179 45     
V4204 
Between Groups 275,594 3 91,865 3,211 0,032 
50 vs 80 
50 vs 90 
80 vs 100 
90 vs 100 
Within Groups 1201,678 42 28,611    
Total 1477,272 45     
V4206 
Between Groups 175,554 3 58,518 5,192 0,004 
50 vs 80 
50 vs 90 
50 vs 100 
90 vs 80 
80 vs 100 
Within Groups 473,377 42 11,271    
Total 648,932 45     
V5104 Between Groups 558,166 3 186,055 5,330 0,003 50 vs 90 
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80 vs 90 
90 vs 100 
Within Groups 1466,224 42 34,910    
Total 2024,390 45     
V5109 
Between Groups 16,115 3 5,372 3,953 0,014 
50 vs 90 
80 vs 90 
90 vs 100 
Within Groups 57,078 42 1,359    
Total 73,192 45     
V6106 
Between Groups 18,475 3 6,158 4,388 0,009 
50 vs 80 
80 vs 90 
80 vs 100 
Within Groups 58,950 42 1,404    
Total 77,425 45     
V6108 
Between Groups 36,866 3 12,289 3,479 0,024 
50 vs 80 
50 vs 90 
90 vs 80 
80 vs 100 
Within Groups 148,332 42 3,532    
Total 185,197 45     
V7106 
Between Groups 50,424 3 16,808 4,396 0,009 
50 vs 90 
80 vs 90 
90 vs 100 
Within Groups 160,580 42 3,823    
Total 211,004 45     
 
Table 1 ANOVA table showing the spots that had a p-value ≤0.05 between groups, the last  columnn on 
the left shows the groups identifyed by the LSD test; 50 stays for the sample group aged 20-50, 80 for 
80-89, 90 for 90-99 and 100 for ≥100. Spots highlighted in blue represent those spots not revealed by 
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Kruskal Wallis test 
 V3 V7 V11 V12 V13 V16 V602 
Chi-Square 9,711 25,957 9,711 19,005 15,483 14,371 12,112 
df 3 3 3 3 3 3 3 
Asymp. Sig. 0,021 0,000 0,021 0,000 0,001 0,002 0,007 
 
 V1307 V2101 V2307 V3101 V3501 V4203 V4105 
Chi-Square 15,331 13,706 10,926 8,645 8,883 18,838 10,268 
df 3 3 3 3 3 3 3 
Asymp. Sig. 0,002 0,003 0,012 0,034 0,031 0,000 0,016 
 
 V4204 V5104 V5106 V6107 V6108 V7106 V6106 
Chi-Square 9,247 8,162 8,902 8,485 12,152 19,490 10,943 
df 3 3 3 3 3 3 3 
Asymp. Sig. 0,026 0,043 0,031 0,037 0,007 0,000 0,012 
 
Table 2 Kruskal Wallis table results, the spots highlighted in blue represents those spots not revealed by 
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a            b 
             
c           d 
Figure 7: Master gels of the four groups with the spots identified by the ANOVA test highlighted in red, a 
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Mass spectrometry and protein identification 
 
 
Of the spots highlighted by the statistical analyses only six were easily sepa-
rated when cutting the gel because some of them were too overlapped for a good 
separation; for this reason we sent to identification only five of them. The identifica-
tions were made using a nano (HP-1200) LC-MS/MS ion trap mass spectrometer. Pep-
tide mass fingerprints of the peptides were identified by database search using MAS-
COT available at www.matrixscience.com with the parameters indicated in materials 
and methods. The table 3 shows how identification confirmed that those spots were 
Clusterin with a reasonable high score. 
 
Spot p-value Protein 
UniProt 
accesion N° 
Mass pI Score Matches Sequences 
V2307 0,007 CLUS_HUMAN P10909 52461 5.89 117 12 (7) 9 (4) 
V4204 0,032 CLUS_HUMAN P10909 52461 5.89 355 27 (17) 13 (11) 
V4206 0,004 CLUS_HUMAN P10909 52461 5.89 205 15 (13) 12 (10) 
V5104 0,003 CLUS_HUMAN P10909 52461 5.89 168 12 (9) 9 (7) 
V5109 0,014 CLUS_HUMAN P10909 52461 5.89 208 14 (10) 12 (8) 
V7106 0,009 CLUS_HUMAN P10909 52461 5.89 126 9 (5) 7 (5) 
 
Table 3: Mass spectrometric identification of spots using the Mascot search engine; matches spectral 
counts, sequences unique peptides. 
 
Analysing the unique peptides retrieved by the mascot search we found that 
they were composed of peptides coming from both the α and the β chain sequences of 
the clusterin protein, suggesting that the spots analysed are a mixture of both chains. 
Chapter 4: Results 
 
PhD ANGELA BARALLA – THESIS TITLE: “CLUSTERIN/APOJ PROTEIN EXPRESSION IN PLASMA SAMPLES OF AN 
ELDERLY SARDINIAN POPULATION” -  PhD IN “SCIENZE BIOMOLECOLARI E BIOTECNOLOGICHE” – UNIVERSITY 
OF SASSARI 
   55 
 
The histogram in fig 8 shows the mean spot intensity variation between groups 
using the normalised quantity values obtained with the software PDQuest, while fig. 9 
shows where these spots are positioned in the cluster of a representative master gel. 
 
  
Figure 8: intensity variation of the six spots identified by mass spectrometry in the four groups. On the y 
axis the intensity values are the ones exported from the analysis with PDQuest, after normalization, 
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Figure 9: Representative master gel with the spots identified highlighted in red. 
 
Western blot analyses 
 
 
For western blot analyses we used an anti-CLU polyclonal antibody. The fig. 10 
shows the bands detected by this antibody on a 1-D gel when 50µg of total protein ex-
tracts were loaded per well. On the left we show a sample under non reducing condi-
tions, while on the right a representative gel of some of the samples investigated, un-
der reducing conditions. 
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a     b 
Figure 10: Immunodetection of CLU by the polyclonal antibody, a under non reducing conditions, b un-
der reducing conditions. 
 
 
Native analysis (fig. 10 a) revealed a smeared band ranging from ~ 70 to 85KDa, 
this mass range fits with the expected molecular mass for the sCLU corresponding to 
the glycosylated heterodimer. Under reducing conditions (fig.10b) we found a set of 
bands of about 40kDa which corresponds to the protein of ~75-80kDa after being re-
duced producing the α and β chains which have similar masses of about 25kDa that 
when glycosylated increase to ~ 40kDa. 
In this gel other bands are visible, of 55, 61 and 28kDa. The size of 55kDa fits 
with the nuclear form of clusterin while the band of 61kDa with the precursor form of 
the secreted clusterin. Moreover the band of 28kDa corresponds to one of the chains 
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(α or β) not glycosylated and they appared only in some of the samples analysed.  
Probably some samples had clusterin proteins with a lower degree of glycosidation and 
their α and/or β chains shifted to a lower molecular weight value. 
The clusterin spots analysed with the 2D-PAGE corresponded to the smeared 
band of ~40kDa and our analysis of quantification concentrated on this band. 
We must take into account that the western blot technique is not completely 
reliable for quantification because the transfer process could introduce artifacts alter-
ing the ratio between bands but surely it can give an idea of what the general behav-
iour is. Below is the histogram representing the mean intensity of the ~ 40kDa band 




Figure 11 The mean percentage of volume contribution of the ~40kDa band evaluated for each group 
with the software Quantity One, the bars represent standard deviations. 
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We wanted to quantify with a more reliable technique the clusterin concentra-
tion in our plasma samples, using an available commercial kit for human clusterin. For 
these analyses we increased the number of samples in order to have robust statistical 
analysis. We found significative differences between the groups 80-89 versus ≥100 and 
90-99 vs ≥100. The table below shows the ANOVA result and the LSD test for the iden-




 Sum of Squares df Mean Square F Sig. 80 vs 100 (0.0003) 
90 vs 100 (0.019) 
Between Groups 9439,028 3 3146,343 5,030 0,003  
Within Groups 40035,193 64 625,550    
Total 49474,221 67     
 
Table 4: ANOVA table showing the spots that had a p-value ≤0.05 between groups, the last  columnn on 
the left shows the groups identifyed by the LSD test with the p-values in brakets. 
 
The table 5 shows the values obtained in the ELISA experiment and the fig. 12 
its graphical representation.  
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Age Sex Mean N Std. Deviation Median Minimum Maximum 
50 Male 53.93638 8 30.229678 58.50250 12.624 111.110 
Female 47.10333 9 18.179783 52.36100 26.284 73.557 
Total 50.31888 17 24.029432 57.42100 12.624 111.110 
80 Male 60.59575 8 32.795181 55.77550 26.494 133.986 
Female 75.20629 7 36.878539 77.53000 24.083 122.121 
Total 67.41400 15 34.315525 61.98800 24.083 133.986 
90 Male 51.61378 9 23.101631 60.76200 15.336 80.385 
Female 58.08988 8 25.011504 60.41400 19.862 96.273 
Total 54.66135 17 23.486882 60.76200 15.336 96.273 
100 Male 34.57950 10 14.114774 31.69700 18.021 70.108 
Female 37.69100 8 20.452230 36.36400 11.612 71.913 
Total 35.96239 18 16.740452 32.21950 11.612 71.913 
Total Male 49.33074 35 26.231899 42.76600 12.624 133.986 
Female 53.64441 32 27.792398 58.56300 11.612 122.121 
Total 51.39100 67 26.870007 50.59100 11.612 133.986 
 
Table 5: Clusterin concentration values in plasma samples with the ELISA assay. 
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Figure 12: Box plots of the clusterin concentration from ELISA experiment showing the distribution of 
data values in the four groups. The bar inside the box indicates the median of distribution, the box 
spanning the interquartile range, and the external bars represents the lowest and highest data points. 
The black dots are ouliers 
As a previous work by Trougakos et. al, reported an increase in CLU serum lev-
els with age in males but not in females (I.P. Trougakos, et al., 2002) we wanted to 
evaluate if the same behaviour was detectable with our plasma samples. 
The box plot in fig.13 shows how the clusterin concentration values vary with 
age in males and females separately. 
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Figure 13: Box plots of the clusterin concentration from ELISA experiment in the four groups in sepa-
rated panels for males and females. 
 
 
The ANOVA analysis (tables 7, 8) showed that for females we have significative 
differences between groups aged 20-50 vs 80-89 and between 80-89 vs ≥100, while for 
males we have a significative difference only between the group aged 80-89 vs ≥100. 
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Adj. Conc.  
 Sum of Squares df Mean Square F Sig.  
Between Groups 7056,622 3 2352,207 3,614 0,025 50 vs 80 (0.037) 
80 vs 100 (0.004) 
Within Groups 18874,746 29 650,853    
Total 25931,368 32     
 
Table 6: ANOVA analyses of the ELISA results only for females, the last  columnn on the left shows the 




Adj. Conc.  
 Sum of Squares df Mean Square F Sig.  
Between Groups 3407,800 3 1135,933 1,762 0,175 80 vs 100 (0.039) 
Within Groups 19988,026 31 644,775    
Total 23395,825 34     
 
Table 7: ANOVA analyses of the ELISA results only for males, the last columnn on the left shows the 
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CLU gene expression was found to increase during in vivo ageing from gestation 
to adults in humans in different tissues like the human pituitary gland (T. Ishikawa, et 
al., 2006), in the rat ventral prostate (K.M. Lau, et al., 2003), in human glial cultures 
(N.V. Patel, et al., 2004) and in human lymphocytes (I.P. Trougakos, et al., 2006).  
Previous work of Trougakos et al., have reported an increase in CLU serum lev-
els with age in males but not in females with the maximum age being 90 years old (I.P. 
Trougakos, et al., 2002).  
In a paper by Franceschi et. al, it was reported that CLU gene expression levels 
increase during ageing but decrease in centenarians. To examine the changes in the 
CLU protein expression we performed a comparative 2D-PAGE study with subjects 
coming from the AkeA Project grouped into 4 classes with ages in the range 20-50, 80-
89, 90-99 and ≥100. In the 2D-gels clusterin appears as a train of spots whose isoelec-
tric point is in the range between 4.65 and 5.65 and molecular weight between 32KDa 
and 40KDa. With the removal of ~60% of albumin with a modified TCA precipitation 
method we were able to resolve a cluster composed of ~16 spots in the position indi-
cated by the reference gel map present in SWISS 2D-PAGE database, but considering 
unique spots coming from each single gel from all the groups this number increased to 
44. 
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The two statistical tests used revealed a group of 10 significative spots using 
the parametric test ANOVA and 21 spots using the non parametric Kruskal Wallis test. 
We decided to analyse our data with both tests because even if parametric tests are 
the ones widely used, they must respect restrictive assumptions like a normal distribu-
tion of the data and homogeneity of variance, which is not always the case in spot in-
tensity values. The non parametric test was able to detect more spots whose values 
vary significantly between groups but some of the spots identified by the ANOVA 
where not identified by the Kruskal Wallis. In this work we had a small number of vari-
ables to compare but the different result obtained when using the two tests might 
suggest that both of them should be used in a first attempt to highlight differentially 
expressed proteins because small variations that can be detected by one test could not 
be highlighted by the other. Of the spots founded by the statistical tests only the ones 
that were easily separated when cutting the gel were sent to mass identification (6 
spots) while for the others that were overlapped between spots or were to faint, 
probably a better separation should be considered for future analyses with enrichment 
methods targeting this protein. LC-MS/MS analyses confirmed the identity of these 
spots as being Clusterin. Fig. 8 shows how the intensity of each spot varies with age. 
The spot V2307 is present only in centenarians, spot V5109 is present only in the group 
aged 90-99 and at a very low value in group 20-50, spot V4204 seems to decrease with 
age and then increase in centenarians, spot V5104 increase until 99 years old and then 
decrease in centenarians, while spot V7106 seems to be present at comparable levels 
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in all the groups except for the 90-99 group, spot V4206 increase until 89 and then de-
crease in the other two groups. 
Considering that a notable feature of secreted clusterin is its heavy glicosyla-
tion, for future analyses, it will be interesting to investigate the types of oligosaccha-
rides attached to the clusterin peptides for each spot in the cluster.  
In the western blot analyses using a polyclonal antibody we detected not only 
the expected band at ~40kDa which is the result of cleavage of the disulfide bonds of 
the mature secreted protein sCLU, but also a band at ~55kDa and ~61kDa. These bands 
fit with the mass of the nuclear form of CLU (nCLU) and with the intracellular precursor 
protein (psCLU) respectively. Why these isoforms appear in our plasma samples is un-
clear, it can be that some cells have been broken during preparation of the samples re-
leasing these proteins which from literature should reside inside the cell. Further in-
vestigation should be necessary to better identify the nature of these bands, even be-
cause they were repeteadly found in all samples analysed. It is also visible a band of 
~28kDa that fits with the polypeptidic backbone of the α or β chain not glycosylated, 
interestingly they appeared only in some of the samples analysed. A deglycosylation 
assay should be performed to determine whether this band is glycosylated. 
The quantitative determination of CLU in plasma samples was evaluated using a 
commercial kit. The boxplot in figure 12 and the p-values in table 4 shows how clus-
terin level significantly differ between the group aged 80-89 and the group of cente-
narians (p=0.0003) and between the group aged 90-99 and centenarians (p=0.019). 
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These results agree with the data shown by literature by the work of Trougakos et al., 
but they stopped investigating at 90 years old, while our work spanned over older 
people showing a decrease after 90 years especially in centenarians. One work taking 
into account centenarians is a paper by Franceschi et al. that evaluated the mRNA lev-
els of CLU from lymphocytes finding a decrease in centenarians. 
The ELISA experiment agrees in some way with the western blot analyses of the 
40 kDa band but the differences between the two assays can be attributed to the 
presence of other isoforms in our samples that we didn’t consider in the western blot 
quantification because we first must be sure that these bands are clusterin, in the fu-
ture we would use monoclonal antibody to increase specificity. In fig.13 we separated 
males from females in the analyses to see if there was any difference in the clusterin 
concentration with age. 
From table 6 we can see that the clusterin mean values are a bit higher in fe-
males than in males in all groups except for the group 20-50. If we look at the general 
behaviour no great differences are visible on the basis of sex, an increase in clusterin 
values until 90 years old is visible and then a decrease in older and centenarian people. 
We can even see that the difference between the groups aged 80-89 and ≥100 is big-
ger in females (p= 0.004) if compared with males (p=0.039). 
As stated in the introduction the CLU gene seems to be a sensitive biosensor of 
environmental insults and particularly oxidative stress which is the driving force of 
most age-related diseases (including cancer) where CLU has functionally being impli-
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cated. So if the clusterin function is to cease the damaging effects of oxidative stress, 
its upregulation should reflect the “general oxidative status” of the subject rather than 
its chronological age (I.P. Trougakos and E.S. Gonos, 2009). Centenarians are consid-
ered as a model of successful ageing characterised by low ROS (reactive oxygen spe-
cies) load (C. Franceschi and M. Bonafe, 2003) and this can be the explanation why we 
found lower level of this protein in plasma. A larger sample size should be investigated 
to confirm the behaviour found in our samples and a comparison with centenarians of 
other countries should also be interesting to analyse to see if they share the same 
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